What is Intensity Therapeutics, Inc. Common stock (INTS) stock price today?

Intensity Therapeutics, Inc. Common stock (INTS) currently trades at $5.21 per share. The stock has a market capitalization of $13.80M and a P/E ratio of —x.

Is INTS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Intensity Therapeutics, Inc. Common stock has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

INTS

Intensity Therapeutics, Inc. Common stock

NASDAQ: INTS · HEALTHCARE · BIOTECHNOLOGY

$5.21

+0.06% today

Updated 2026-05-06

Market cap

$13.80M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-8.56

Dividend yield

—

52W range

$5 – $44

Volume

0.0M

Market cap

$13.80M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-8.56

Dividend yield

—

52W range

$5 – $44

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →197 stocks currently score above 75

Price targets

Analyst target

$41.50

+696.55%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.40M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$-26000.00
Net income	$-7.58M	$-10.54M	$-16.27M	$-11.61M	$-3.05M
EPS	—	—	—	—	$-8.56
Free cash flow	$-5.48M	$-7.21M	$-15.22M	$-9.23M	$-2.40M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
INTS	$13.80M	23	4.3	3.0	5.0	5.0	—	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-40.34%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-22.55%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+43.12%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Smart narrative

Intensity Therapeutics, Inc. Common stock trades at $5.21. Our Smart Value Score of 23/100 indicates the stock is weak.

Frequently asked questions

What is Intensity Therapeutics, Inc. Common stock's stock price?

Intensity Therapeutics, Inc. Common stock (INTS) trades at $5.21.

Is Intensity Therapeutics, Inc. Common stock overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Intensity Therapeutics, Inc. Common stock (INTS)?

The analyst target price is $41.50, representing +696.5% upside from the current price of $5.21.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.intensitytherapeutics.com

Quick metrics

P/S ratio—

ROE-156.90%

Beta3.26

50D MA$6.16

200D MA$8.17

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

INTS vs LLY →INTS vs JNJ →INTS vs ABBV →Stock screener →